Adrien Monard
Impact in
-
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Pharmaceutical Economics and Policy
Papers in
- Oncology 4
- CAR-T cell therapy research 1
- Peptidase Inhibition and Analysis 1
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Pharmaceutical Economics and Policy 3
- Economic and Financial Impacts of Cancer 2
- Co-authors
- Nicolas Albin (7 shared papers)Emmanuelle Jacquet (3 shared papers)Jean‐Yves Blay (1 shared paper)Natalie Hoog-Labouret (2 shared papers)Claire Le Jeunne (2 shared papers)B. Guillot (1 shared paper)F. Lavie (2 shared papers)Jean‐François Bergmann (2 shared papers)
- Journals
- Cancer (1 paper)International Journal of Cancer (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Clinical and Translational Gastroenterology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- France
In The Last Decade
Adrien Monard
7 papers receiving 32 citations
Peers
Comparison fields: 5 of 15
- Economics and Econometrics 25
- Geriatrics and Gerontology 2
- Occupational Therapy 2
- Oncology 12
- Physiology 7
Countries citing papers authored by Adrien Monard
This map shows the geographic impact of Adrien Monard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Monard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Monard more than expected).
Fields of papers citing papers by Adrien Monard
This network shows the impact of papers produced by Adrien Monard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Monard. The network helps show where Adrien Monard may publish in the future.
Co-authors
The 12 scholars most cited alongside Adrien Monard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | 2022 | 8 | |
| 3 | 2018 | 6 | |
| 4 | 2021 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2018 | 2 | |
| 7 | 2024 | 1 |
About Adrien Monard
Adrien Monard is a scholar working on Oncology, Economics and Econometrics, Physiology, Pulmonary and Respiratory Medicine and Immunology, having authored 7 papers that have together received 34 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (3 papers), Biomedical Ethics and Regulation (3 papers), Economic and Financial Impacts of Cancer (2 papers), CAR-T cell therapy research (1 paper), Cancer Genomics and Diagnostics (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Economics and Econometrics (25 citations), Geriatrics and Gerontology (2 citations), Occupational Therapy (2 citations), Oncology (12 citations) and Physiology (7 citations). Adrien Monard has collaborated with scholars based in France. Frequent co-authors include Nicolas Albin, Emmanuelle Jacquet, Jean‐Yves Blay, Natalie Hoog-Labouret, Claire Le Jeunne, B. Guillot, F. Lavie, Jean‐François Bergmann, Olivier Blin and Nadia Haddy. Their work appears in journals such as Cancer, International Journal of Cancer, Cancer Chemotherapy and Pharmacology, Clinical and Translational Gastroenterology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.